02397cam a2200433 i 4500 rnd000000000111884 RAND 930407s1993 caua b 000 0 eng d 93012592 0833013459 RAND/MR-166-DPRC (Sirsi) a337046 $13.00 CstmoR CstmoR n-us--- HD7102.U4 R554 Rogowski, Jeannette A. author. Private versus public sector insurance coverage for drug abuse / Jeannette A. Rogowski. Santa Monica, CA : RAND, 1993. xi, 53 pages : illustrations ; 28 cm text txt rdacontent computer c rdamedia unmediated n rdamedia online resource cr rdacarrier volume nc rdacarrier "Drug Policy Research Center." Includes bibliographical references (p. 51-53). This study examined financing mechanisms currently in place for treating drug abuse, focusing primarily on differences between private and public insurance mechanisms. Within the private sector, insurance coverage for drug abuse treatment is quite restrictive. Limitations typically exist on the type and amount of treatment that can be received per year or per lifetime, and benefits may quickly be exhausted. Limitations also exist with regard to public insurance funding. Eligibility requirements and the authorized settings in which care may be provided are extremely restrictive. It has been argued that public funding for drug abuse should be mainstreamed into Medicaid. However, this is not likely to occur due to significant institutional barriers, and in particular to the highly restrictive eligibility requirements for public programs. Also available on the internet via WWW in PDF format. Description based on print version record. United States. Office of Civilian Health and Medical Program of the Uniformed Services. Drug abuse Treatment United States Finance. Insurance, Health United States. Medicaid. Medicare. RAND Drug Policy Research Center. Ford Foundation. Weingart Foundation. Online Access http://www.rand.org/pubs/monograph_reports/2006/MR166.pdf 599386 599386